Advances in nutritional therapy in inflammatory bowel diseases: Review
- PMID: 26811646
- PMCID: PMC4716019
- DOI: 10.3748/wjg.v22.i3.1045
Advances in nutritional therapy in inflammatory bowel diseases: Review
Abstract
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease are chronic, life-long, and relapsing diseases of the gastrointestinal tract. Currently, there are no complete cure possibilities, but combined pharmacological and nutritional therapy may induce remission of the disease. Malnutrition and specific nutritional deficiencies are frequent among IBD patients, so the majority of them need nutritional treatment, which not only improves the state of nutrition of the patients but has strong anti-inflammatory activity as well. Moreover, some nutrients, from early stages of life are suspected as triggering factors in the etiopathogenesis of IBD. Both parenteral and enteral nutrition is used in IBD therapy, but their practical utility in different populations and in different countries is not clearly established, and there are sometimes conflicting theories concerning the role of nutrition in IBD. This review presents the actual data from research studies on the influence of nutrition on the etiopathogenesis of IBD and the latest findings regarding its mechanisms of action. The use of both parenteral and enteral nutrition as therapeutic methods in induction and maintenance therapy in IBD treatment is also extensively discussed. Comparison of the latest research data, scientific theories concerning the role of nutrition in IBD, and different opinions about them are also presented and discussed. Additionally, some potential future perspectives for nutritional therapy are highlighted.
Keywords: Dietary factors; Etiology; Exclusive enteral nutrition; Induction therapy; Inflammatory bowel disease; Maintenance therapy; Nutritional therapy; Parenteral nutrition.
Figures
Similar articles
-
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23. Gastroenterology. 2024. PMID: 38276922
-
Diet therapy for inflammatory bowel diseases: The established and the new.World J Gastroenterol. 2016 Feb 21;22(7):2179-94. doi: 10.3748/wjg.v22.i7.2179. World J Gastroenterol. 2016. PMID: 26900283 Free PMC article. Review.
-
[ESPEN guideline: Clinical nutrition in inflammatory bowel disease].Nutr Hosp. 2022 Jun 24;39(3):678-703. doi: 10.20960/nh.03857. Nutr Hosp. 2022. PMID: 35014851 Review. Spanish.
-
Effect of long-lasting nutritional prehabilitation on postoperative outcome in elective surgery for IBD.Clin Nutr. 2021 Mar;40(3):928-935. doi: 10.1016/j.clnu.2020.06.020. Epub 2020 Jul 1. Clin Nutr. 2021. PMID: 32684485
-
Allergic and Immunologic Perspectives of Inflammatory Bowel Disease.Clin Rev Allergy Immunol. 2019 Oct;57(2):179-193. doi: 10.1007/s12016-018-8690-3. Clin Rev Allergy Immunol. 2019. PMID: 29754190 Review.
Cited by
-
Enhancing Calprotectin's Predictive Power as a Biomarker of Endoscopic Activity in Ulcerative Colitis: A Machine Learning Use Case.Biomedicines. 2024 Feb 20;12(3):475. doi: 10.3390/biomedicines12030475. Biomedicines. 2024. PMID: 38540089 Free PMC article.
-
Calprotectin Is Associated with HETE and HODE Acids in Inflammatory Bowel Diseases.J Clin Med. 2023 Dec 8;12(24):7584. doi: 10.3390/jcm12247584. J Clin Med. 2023. PMID: 38137653 Free PMC article.
-
Diet as an epigenetic factor in inflammatory bowel disease.World J Gastroenterol. 2023 Nov 7;29(41):5618-5629. doi: 10.3748/wjg.v29.i41.5618. World J Gastroenterol. 2023. PMID: 38077158 Free PMC article. Review.
-
The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease-What Is the Clinical Evidence So Far?Life (Basel). 2023 Aug 8;13(8):1703. doi: 10.3390/life13081703. Life (Basel). 2023. PMID: 37629560 Free PMC article. Review.
-
Fuc-S-A New Ultrasonic Degraded Sulfated α-l-Fucooligosaccharide-Alleviates DSS-Inflicted Colitis through Reshaping Gut Microbiota and Modulating Host-Microbe Tryptophan Metabolism.Mar Drugs. 2022 Dec 25;21(1):16. doi: 10.3390/md21010016. Mar Drugs. 2022. PMID: 36662189 Free PMC article.
References
-
- Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12 Suppl 1:S3–S9. - PubMed
-
- Goyette P, Labbé C, Trinh TT, Xavier RJ, Rioux JD. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med. 2007;39:177–199. - PubMed
-
- O’Sullivan M, O’Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2006;20:561–573. - PubMed
-
- Alastair F, Emma G, Emma P. Nutrition in inflammatory bowel disease. JPEN J Parenter Enteral Nutr. 2011;35:571–580. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical